Multiple N-of-1 trials to investigate hypoxia-based treatment in Parkinson’s disease: safety and short-term effects
Objective: In this study, we describe the safety and short-term effects of the first hypoxia-based treatment trial in Parkinson’s disease by deploying a personalized multiple…An IMU- based Objective Quantification Method for Bradykinesia Evaluation in Parkinson’s disease
Objective: Proposing an inertial measurement unit (IMU)-based objective quantification method for bradykinesia evaluation in Parkinson’s disease (PD) using MDS UPDRS III. Background: MDS-UPDRS III rating…Efficacy of subthalamic nucleus deep brain stimulation in Parkinson’s disease: A preliminary Thailand experience
Objective: To evaluate the efficacy and adverse events of subthalamic nucleus deep brain stimulation (STN-DBS) in Thai patients with Parkinson’s disease (PD). Background: Bilateral STN-DBS…Parkinsonian tremor secondary to Sinking flap syndrome – An atypical presentation
Objective: The association of sinking flap syndrome with Parkinsonian tremors is very rare Background: The association of sinking flap syndrome with Parkinsonian tremors is very…Validation of the Japanese version of the King’s Parkinson’s Disease Pain Scale and the King’s Parkinson’s Disease Pain Questionnaire
Objective: The purpose of this study is a validation of the Japanese version of the King's Parkinson's Disease Pain Scale (KPPS) and the King's Parkinson's…Building and evaluating a speech biomarker from 2-seconds sustained phonation to detect and monitor Parkinson’s disease
Objective: The aim of this work was to evaluate the feasibility of a speech-based algorithm geared towards frequent remote measuring of Parkinson’s disease severity with…Dopamine dysregulation syndrome in Parkinson’s disease controlled by safinamine
Objective: To describe a case of dopamine dysregulation syndrome managed by safinamide. Background: Dopamine dysregulation syndrome (DDS) is an uncommon non-motor symptom of Parkinson disease…Nocturnal behavior of people with Parkinson’s disease
Objective: Compare the nocturnal energy expenditure (kcal) and activity behavior of people with PD using a real-time wearable sensor, and determine whether these outcomes differed…Safety in Levodopa/carbidopa Intestinal Gel (LCGI) titration in the Intensive Care Unit (ICU) setting for Parkinson’s Disease (PD) patient with severe dysphagia
Objective: Describe a PD patient with obsessive-compulsive disorder (OCD) and paranoid symptoms in whom treatment with LCIG was started in the ICU due to severe…Enrollment phase sensing data from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) clinical trial
Objective: To describe enrollment sensing data from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) trial (NCT04547712). Background: Local field potential (LFP)…
- « Previous Page
- 1
- …
- 99
- 100
- 101
- 102
- 103
- …
- 338
- Next Page »